These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19583830)

  • 1. Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.
    Worschech A; Chen N; Yu YA; Zhang Q; Pos Z; Weibel S; Raab V; Sabatino M; Monaco A; Liu H; Monsurró V; Buller RM; Stroncek DF; Wang E; Szalay AA; Marincola FM
    BMC Genomics; 2009 Jul; 10():301. PubMed ID: 19583830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
    Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
    Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
    Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
    Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
    Hofmann E; Weibel S; Szalay AA
    J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy.
    Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M
    Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
    Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
    Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
    Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
    J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
    Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
    PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective oncolytic vaccinia therapy for human sarcomas.
    He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ
    J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
    Wang H; Chen NG; Minev BR; Szalay AA
    J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus.
    Haddad D; Chen NG; Zhang Q; Chen CH; Yu YA; Gonzalez L; Carpenter SG; Carson J; Au J; Mittra A; Gonen M; Zanzonico PB; Fong Y; Szalay AA
    J Transl Med; 2011 Mar; 9():36. PubMed ID: 21453532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
    Schäfer S; Weibel S; Donat U; Zhang Q; Aguilar RJ; Chen NG; Szalay AA
    BMC Cancer; 2012 Aug; 12():366. PubMed ID: 22917220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
    Hofmann E; Grummt F; Szalay AA
    Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy.
    Frentzen A; Yu YA; Chen N; Zhang Q; Weibel S; Raab V; Szalay AA
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12915-20. PubMed ID: 19617539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.
    Seubert CM; Stritzker J; Hess M; Donat U; Sturm JB; Chen N; von Hof JM; Krewer B; Tietze LF; Gentschev I; Szalay AA
    Cancer Gene Ther; 2011 Jan; 18(1):42-52. PubMed ID: 20829890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.
    Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA
    BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models.
    Cecil A; Gentschev I; Adelfinger M; Dandekar T; Szalay AA
    Bioengineered; 2019 Dec; 10(1):190-196. PubMed ID: 31142183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.